Anna Dankowska-Lojko

Poznan, WP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Corrigendum to "Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study" EClinicalMedicine. 2025 Jul 25:86:103383.

Corrigendum to "Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study" EClinicalMedicine. 2025 Jul 25:86:103383.

Journal: EClinicalMedicine

Published: April 21, 2026

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.

Journal: The Lancet. Haematology

Published: November 21, 2025

Introducing CAR T-cell therapy into clinical practice for mantle cell lymphoma: real-world experience from Poland.

Introducing CAR T-cell therapy into clinical practice for mantle cell lymphoma: real-world experience from Poland.

Journal: Archives of medical science : AMS

Published: October 29, 2025

CD34+/CD3+ cells ratio in the peripheral blood stem cells product and graft-versus-host disease: Is there still room for improvement?

CD34+/CD3+ cells ratio in the peripheral blood stem cells product and graft-versus-host disease: Is there still room for improvement?

Journal: Transplant immunology

Published: October 03, 2025

Challenging and Successful Therapy Decision-Making for AML Post Cytotoxic Therapy and Concomitant Active Breast Cancer - A Case Report and Experience-Driven Strategy.

Challenging and Successful Therapy Decision-Making for AML Post Cytotoxic Therapy and Concomitant Active Breast Cancer - A Case Report and Experience-Driven Strategy.

Journal: Breast cancer (Dove Medical Press)

Published: May 15, 2025

Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study.

Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study.

Journal: EClinicalMedicine

Published: March 14, 2025

Genetic background of Richter transformation of atypical chronic lymphocytic leukemia to diffuse large B-cell lymphoma - a case study.

Genetic background of Richter transformation of atypical chronic lymphocytic leukemia to diffuse large B-cell lymphoma - a case study.

Journal: Journal of applied genetics

Published: March 12, 2025

Should we Cryopreserve Allogenic Hematopoietic Stem Cell Grafts?

Should we Cryopreserve Allogenic Hematopoietic Stem Cell Grafts?

Journal: In vivo (Athens, Greece)

Published: November 12, 2024

Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.

Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.

Journal: Polish archives of internal medicine

Published: May 15, 2024

Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma.

Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma.

Journal: Blood

Published: February 13, 2024

Evaluation of elafin as a marker of skin fibrosis -a preliminary study.

Evaluation of elafin as a marker of skin fibrosis -a preliminary study.

Journal: Archives of dermatological research

Published: December 19, 2023

Acute Myeloid Leukemia Post Cytotoxic Therapy in Breast Cancer Survivors-Over 23 Years of Single Center Analysis.

Acute Myeloid Leukemia Post Cytotoxic Therapy in Breast Cancer Survivors-Over 23 Years of Single Center Analysis.

Journal: Journal of clinical medicine

Published: December 14, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026